Samsara Bio Capital, LLC Gossamer Bio, Inc. Call Options Transaction History
Samsara Bio Capital, LLC
- $217 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GOSS
# of Institutions
122Shares Held
160MCall Options Held
2.11MPut Options Held
57.8K-
Octagon Capital Advisors LP New York, NY18.4MShares$19.3 Million6.72% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$19 Million1.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$10.6 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$8.46 Million7.27% of portfolio
-
Silverarc Capital Management, LLC6.32MShares$6.64 Million1.69% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $98.7M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...